Back to Newsroom

Xconomy: Cellular Dynamics, Seizing the Present, Turns Stem Cells into Cash

Stories like Cellular Dynamics don’t grab venture capitalists in Boston or the San Francisco Bay Area. Stem cell biology as the basis for a low-margin laboratory “services” business? Borrrring. Most of the big thinkers and the big moneymen are more excited about stem cells as “regenerative medicines” that would cost a fortune and could potentially help paralyzed people get up and walk.